A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
- AK Burnett
- , Donald Milligan
- , AG Prentice
- , AH Goldstone
- , MF McMullin
- , Robert Hills
- , Keith Wheatley
Research output: Contribution to journal › Article
442
Citations
(Scopus)